Filing Flows › Comparisons › CV vs NRXS
CapsoVision vs Neuraxis: CV and NRXS compared
CapsoVision is the larger company: $3.6M of revenue in its latest quarter (Q2 2026) against $1.9M for Neuraxis (Q2 2026). Neuraxis is growing faster (+116% against +10% a year earlier). Neuraxis is more profitable, with an operating margin of -110.2% against -208.1%.
Where the money goes: CV and NRXS
CapsoVision (CV) · Q2 2026
CapsoVision, Q2 2026: revenue $3.6M (+10% year over year), operating margin -208.1%, net loss $7.5M, operating cash flow −$8.4M. The chart follows the revenue to costs, profit and cash.
Neuraxis (NRXS) · Q2 2026
Neuraxis, Q2 2026: revenue $1.9M (+116% year over year), operating margin -110.2%, net loss $2.1M, operating cash flow −$1.0M. The chart follows the revenue to costs, profit and cash.
| CapsoVision (CV) | Neuraxis (NRXS) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $3.6M | $1.9M |
| Revenue growth, Y/Y | +10% | +116% |
| Operating margin | -208.1% | -110.2% |
| Net earnings | −$7.5M | −$2.1M |
| Net margin | -205.4% | -108.1% |
| Operating cash flow | −$8.4M | −$1.0M |
Questions
Which is bigger, CapsoVision or Neuraxis?
CapsoVision is the larger company: $3.6M of revenue in its latest quarter (Q2 2026) against $1.9M for Neuraxis (Q2 2026).
Is CapsoVision or Neuraxis growing faster?
Neuraxis is growing faster (+116% against +10% a year earlier).
Which is more profitable, CapsoVision or Neuraxis?
Neuraxis is more profitable, with an operating margin of -110.2% against -208.1%.
More: CapsoVision earnings · how CapsoVision makes money · Neuraxis earnings · how Neuraxis makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.